V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029496 | 20012565 | 1.59 | 69 | Not known (9) | 2016-04-05 | 2016-04-05 | FEC 100 + DOCETAXEL | 02 | N | 20103954 | FEC + DOCETAXEL |
| 20029497 | 20012566 | 1.62 | 78.8 | Not known (9) | 2014-09-28 | 2014-10-16 | FEC + DOCETAXEL | 02 | N | 20103955 | FEC + DOCETAXEL |
| 20029498 | 20012566 | 1.63 | 91 | Adjuvant (A) | 2015-02-22 | 2015-03-09 | FEC + DOCETAXEL | N | N | 20103955 | FEC + DOCETAXEL |
| 20029499 | 20012566 | null | 87.1 | Neo-adjuvant (N) | 2013-10-04 | 2013-10-19 | FEC + DOCETAXEL | N | null | 20103955 | FEC + DOCETAXEL |
| 20029500 | 20012567 | null | 80.5 | Adjuvant (A) | 2018-01-25 | 2018-02-01 | FEC + DOCETAXEL | N | N | 20103970 | FEC + DOCETAXEL |
| 20029501 | 20012567 | 1.56 | 64.6 | Adjuvant (A) | 2015-11-02 | 2015-11-16 | FEC 100 + DOCETAXEL | N | N | 20103970 | FEC + DOCETAXEL |
| 20029502 | 20012568 | 1.63 | 139.8 | Adjuvant (A) | 2015-06-01 | 2015-06-15 | FEC + DOCETAXEL | 2 | N | 20103979 | FEC + DOCETAXEL |
| 20029503 | 20012568 | 0 | 83.2 | Adjuvant (A) | null | 2017-07-30 | FEC + DOCETAXEL | N | N | 20103979 | FEC + DOCETAXEL |
| 20029504 | 20012569 | 1.74 | null | Adjuvant (A) | 2016-12-01 | 2016-12-08 | FEC 100 + DOCETAXEL | N | null | 20103982 | FEC + DOCETAXEL |
| 20029505 | 20012569 | 1.65 | 91.7 | Adjuvant (A) | 2016-09-10 | 2016-10-01 | FEC + DOCETAXEL | N | null | 20103982 | FEC + DOCETAXEL |
| 20029506 | 20012570 | null | 109 | Adjuvant (A) | null | 2015-03-22 | FEC 100 + DOCETAXEL | N | N | 20103984 | FEC + DOCETAXEL |
| 20029507 | 20012570 | 1.63 | 79 | null | 2013-03-26 | 2013-04-12 | FEC + DOCETAXEL | 99 | null | 20103984 | FEC + DOCETAXEL |
| 20029508 | 20012571 | 1.71 | 80.2 | Adjuvant (A) | 2016-09-25 | 2016-10-13 | FEC + DOCETAXEL | 02 | Y | 20103988 | FEC + DOCETAXEL |
| 20029509 | 20012571 | 1.6 | 56.5 | Adjuvant (A) | 2014-09-26 | 2014-09-02 | FEC 100 + DOCETAXEL | 02 | N | 20103988 | FEC + DOCETAXEL |
| 20029510 | 20012572 | 1.64 | 90.9 | Adjuvant (A) | null | 2016-10-18 | FEC 100 + DOCETAXEL | n | null | 20103993 | FEC + DOCETAXEL |
| 20029511 | 20012573 | 1.67 | 85 | Adjuvant (A) | 2017-08-16 | 2017-08-25 | FEC + DOCETAXEL | 02 | N | 20103999 | FEC + DOCETAXEL |
| 20029512 | 20012573 | 1.64 | 91.8 | Adjuvant (A) | 2017-10-10 | 2017-10-19 | FEC + DOCETAXEL | 02 | N | 20103999 | FEC + DOCETAXEL |
| 20029513 | 20012574 | 1.64 | 58.4 | Neo-adjuvant (N) | 2014-04-21 | 2014-05-06 | FEC + DOCETAXEL | 2 | N | 20104005 | FEC + DOCETAXEL |
| 20029514 | 20012574 | 1.61 | 67.2 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-20 | FEC + DOCETAXEL | 02 | N | 20104005 | FEC + DOCETAXEL |
| 20029515 | 20012575 | null | 72 | Adjuvant (A) | 2013-06-13 | 2013-06-28 | FEC 100 + DOCETAXEL | N | null | 20104014 | FEC + DOCETAXEL |
| 20029516 | 20012576 | null | 87 | null | 2013-03-17 | 2013-04-10 | FEC + DOCETAXEL | N | N | 20104015 | FEC + DOCETAXEL |
| 20029517 | 20012576 | null | 79 | Adjuvant (A) | 2017-11-08 | 2017-11-30 | FEC + DOCETAXEL | N | N | 20104015 | FEC + DOCETAXEL |
| 20029518 | 20012576 | 1.61 | 89.45 | null | 2015-12-21 | 2016-01-02 | FEC 100 + DOCETAXEL | N | null | 20104015 | FEC + DOCETAXEL |
| 20029519 | 20012576 | 1.68 | 52 | Neo-adjuvant (N) | 2017-01-17 | 2017-01-17 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20104015 | FEC + DOCETAXEL |
| 20029520 | 20012576 | 1.63 | 61.4 | Neo-adjuvant (N) | 2014-04-28 | 2014-05-04 | FEC + DOCETAXEL | 2 | N | 20104015 | FEC + DOCETAXEL |
| 20029521 | 20012576 | 1.59 | 69 | Neo-adjuvant (N) | 2017-09-11 | 2017-09-11 | FEC + DOCETAXEL | 02 | N | 20104015 | FEC + DOCETAXEL |
| 20029522 | 20012576 | 1.64 | 77.3 | Adjuvant (A) | 2016-05-13 | 2016-05-17 | FEC 60 OR 75 + DOCETAXEL | 2 | N | 20104015 | FEC + DOCETAXEL |
| 20029523 | 20012577 | 1.66 | null | Adjuvant (A) | 2013-09-07 | 2013-09-30 | FEC + DOCETAXEL | N | N | 20104041 | FEC + DOCETAXEL |
| 20029524 | 20012577 | 1.67 | 63.9 | Curative (C) | 2014-02-02 | 2014-02-02 | FEC + DOCETAXEL | 02 | N | 20104041 | FEC + DOCETAXEL |
| 20029525 | 20012577 | 1.58 | 45.8 | Adjuvant (A) | null | 2014-03-05 | FEC + DOCETAXEL | N | N | 20104041 | FEC + DOCETAXEL |
| 20029526 | 20012578 | 1.51 | 49 | Adjuvant (A) | 2016-08-26 | 2016-09-14 | FEC + DOCETAXEL | N | N | 20104051 | FEC + DOCETAXEL |
| 20029527 | 20012578 | 1.53 | 58 | Not known (9) | 2014-07-26 | 2014-08-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20104051 | FEC + DOCETAXEL |
| 20029528 | 20012579 | null | 82.399 | Neo-adjuvant (N) | 2014-08-03 | 2014-08-10 | FEC + DOCETAXEL | N | null | 20104056 | FEC + DOCETAXEL |
| 20029529 | 20012579 | null | 70.65 | Adjuvant (A) | 2015-01-26 | 2015-01-27 | FEC 100 + DOCETAXEL | N | N | 20104056 | FEC + DOCETAXEL |
| 20029530 | 20012580 | 1.68 | 67 | Neo-adjuvant (N) | 2015-12-05 | 2015-12-05 | FEC + DOCETAXEL | 02 | N | 20104058 | FEC + DOCETAXEL |
| 20029531 | 20012581 | 1.68 | 84.7 | Neo-adjuvant (N) | 2013-01-02 | 2013-01-24 | FEC 100 + DOCETAXEL | N | N | 20104059 | FEC + DOCETAXEL |
| 20029532 | 20012581 | 1.53 | 83 | Curative (C) | 2016-09-27 | 2016-10-01 | FEC + DOCETAXEL | 2 | N | 20104059 | FEC + DOCETAXEL |
| 20029533 | 20012582 | 1.63 | 64.8 | Adjuvant (A) | null | 2015-02-03 | FEC + DOCETAXEL | N | N | 20104065 | FEC + DOCETAXEL |
| 20029534 | 20012582 | 1.67 | 60 | Not known (9) | 2015-10-28 | 2015-10-30 | FEC 100 + DOCETAXEL | 02 | N | 20104065 | FEC + DOCETAXEL |
| 20029535 | 20012582 | 1.46 | 57 | Not known (9) | 2014-06-21 | 2014-06-22 | FEC + DOCETAXEL | 2 | N | 20104065 | FEC + DOCETAXEL |
| 20029536 | 20012582 | 1.67 | 56.1 | Adjuvant (A) | null | 2014-06-18 | FEC 100 + DOCETAXEL | N | N | 20104065 | FEC + DOCETAXEL |
| 20029537 | 20012583 | 1.63 | 65.6 | null | 2015-10-04 | 2015-10-04 | FEC 100 + DOCETAXEL | 2 | N | 20104073 | FEC + DOCETAXEL |
| 20029538 | 20012583 | 1.75 | 47.7 | Adjuvant (A) | 2015-04-25 | 2015-04-25 | FEC + DOCETAXEL | N | N | 20104073 | FEC + DOCETAXEL |
| 20029539 | 20012584 | 1.58 | 81.8 | Adjuvant (A) | 2017-02-07 | 2017-02-17 | FEC + DOCETAXEL | 2 | N | 20104076 | FEC + DOCETAXEL |
| 20029540 | 20012585 | 1.73 | 76.6 | Adjuvant (A) | 2016-05-14 | 2016-05-21 | FEC + DOCETAXEL | 02 | Y | 20104077 | FEC + DOCETAXEL |
| 20029541 | 20072577 | 1.86 | 76 | Neo-adjuvant (N) | 2013-09-15 | 2013-09-15 | FEC + DOCETAXEL | 2 | N | 20104078 | FEC + DOCETAXEL |
| 20029542 | 20012586 | 1.68 | 87.1 | Adjuvant (A) | 2014-05-28 | 2014-06-15 | FEC + DOCETAXEL | N | N | 20104092 | FEC + DOCETAXEL |
| 20029543 | 20012586 | 1.73 | 119.8 | Curative (C) | 2016-07-25 | 2016-08-08 | FEC + DOCETAXEL | 02 | null | 20104092 | FEC + DOCETAXEL |
| 20029544 | 20012586 | null | 82 | Adjuvant (A) | null | 2017-08-30 | FEC + DOCETAXEL | N | N | 20104092 | FEC + DOCETAXEL |
| 20029545 | 20012587 | 1.61 | null | Adjuvant (A) | 2015-01-03 | 2015-03-17 | FEC + DOCETAXEL | 2 | N | 20104097 | FEC + DOCETAXEL |